The concentration of your final solution depends entirely on how much water you add
Another key question is whether psychiatric effects are direct or secondary to metabolic improvements
So it was a twice-a-day shot, which barely cleared the hurdle of good enough to be a drug, but we made it into a drug along with our partner Amylin and launched that in 2006
Deboever, N, Bayley, EM, Eisenberg, M, Hofstetter, WL, Mehran, RJ, Rice, DC, Rajaram, R, Roth, JA, Sepesi, B, Swisher, SG, Vaporciyan, AA, Walsh, GL, Bednarski, BK, Morris, VK, Antonoff, MB
Tirzepatide and renal outcomes Tirzepatide Tirzepatide is a dual GIP/GLP-1 receptor agonist designed to engage complementary mechanisms and elicit synergistic and more efficacious responses with respect to monoagonists [39]